M1 Kliniken AG (FRA:M12)

Market Cap	344.01M
Revenue (ttm)	354.98M
Net Income (ttm)	17.74M
Shares Out	n/a
EPS (ttm)	0.95
PE Ratio	19.39
Forward PE	19.01
Dividend	0.50 (2.68%)
Ex-Dividend Date	Jul 17, 2025

Volume	255
Average Volume	137
Open	18.40
Previous Close	18.52
Day's Range	18.40 - 18.68
52-Week Range	12.88 - 19.48
Beta	n/a
RSI	64.85
Earnings Date	Jun 5, 2026

About M1 Kliniken AG

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; abdominoplastic and nose correction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segmen...

• Industry: Hospitals
• Founded: 2007
• Employees: 199
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: M12

Financial Performance

In 2024, M1 Kliniken AG's revenue was 339.18 million, an increase of 7.23% compared to the previous year's 316.32 million. Earnings were 16.02 million, an increase of 55.91%.